Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia

Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia Purpose of Review In this review, we summarise the evidence health worldwide. The NO pathway may be a promising bio- on the association between cardiovascular disease (CVD) and logical candidate for future studies focused on reducing not cognitive impairment and explore the role of the nitric oxide only CVD but also risk of cognitive decline and dementia. (NO) pathway as a causal mechanism. . . Recent Findings Evidence from epidemiological studies sug- Keywords Cardiovascular disease Cognitive impairment . . gests that the presence of CVD and its risk factors in midlife is Dementia Endothelial function Nitric oxide associated with an increased risk of later life cognitive impair- ment and dementia. It is unclear what is driving this associa- tion but risk may be conveyed via an increase in neurodegen- Introduction eration (e.g. amyloid deposition), vascular changes (e.g. small vessel disease) and mechanistically due to increased levels of Midlife cardiovascular disease (CVD) and vascular risk fac- oxidative stress and inflammation as well as changes in NO tors have been consistently associated with an increased risk bioavailability. of later life cognitive impairment and dementia [1–3]. The underlying mechanisms explaining how CVDs and their risk factors negatively affect cognitive function are complex, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Cardiology Reports Springer Journals

Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia

Loading next page...
 
/lp/springer_journal/cardiovascular-disease-the-nitric-oxide-pathway-and-risk-of-cognitive-hgWLqWNI04
Publisher
Springer US
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Cardiology
ISSN
1523-3782
eISSN
1534-3170
D.O.I.
10.1007/s11886-017-0898-y
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review In this review, we summarise the evidence health worldwide. The NO pathway may be a promising bio- on the association between cardiovascular disease (CVD) and logical candidate for future studies focused on reducing not cognitive impairment and explore the role of the nitric oxide only CVD but also risk of cognitive decline and dementia. (NO) pathway as a causal mechanism. . . Recent Findings Evidence from epidemiological studies sug- Keywords Cardiovascular disease Cognitive impairment . . gests that the presence of CVD and its risk factors in midlife is Dementia Endothelial function Nitric oxide associated with an increased risk of later life cognitive impair- ment and dementia. It is unclear what is driving this associa- tion but risk may be conveyed via an increase in neurodegen- Introduction eration (e.g. amyloid deposition), vascular changes (e.g. small vessel disease) and mechanistically due to increased levels of Midlife cardiovascular disease (CVD) and vascular risk fac- oxidative stress and inflammation as well as changes in NO tors have been consistently associated with an increased risk bioavailability. of later life cognitive impairment and dementia [1–3]. The underlying mechanisms explaining how CVDs and their risk factors negatively affect cognitive function are complex,

Journal

Current Cardiology ReportsSpringer Journals

Published: Aug 11, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off